AST and Marchesini Group Showcase Innovative Drug Manufacturing Solutions at INTERPHEX 2026

AST and Marchesini Group, two prominent players in the pharmaceutical equipment manufacturing sector, are making a notable appearance at INTERPHEX 2026, scheduled from April 21 to 23 in New York. This collaboration, which was first announced in December 2025, aims to enhance the production and inspection of sterile pharmaceutical products that meet stringent Good Manufacturing Practices (GMP).

With their combined expertise, AST and Marchesini aim to accelerate the delivery of state-of-the-art technologies designed for the evolving needs of pharmaceutical companies. The partnership extends the geographical footprint of both organizations in the U.S. and European markets, facilitating increased production capabilities and resource sharing to meet the demands of both existing and prospective customers.

AST’s integration into Marchesini Group's Aseptic Business Unit marks a significant growth opportunity, particularly in the Americas. It offers AST a unique position to leverage Marchesini’s established networks, thereby enhancing its service offerings and support capabilities on a global scale. AST has also contributed its specialized solutions, such as robotic systems that are pivotal for the aseptic filling and closing processes crucial to the biotech and pharmaceutical sectors. This technology complements the existing strengths of Marchesini Group, which includes experts in filling sterile products, automated inspection systems, and precision powder filling.

Among the technologies set to be showcased at INTERPHEX are AST’s GENiSYS® R and CMP Phar.ma’s NSY 200. These systems represent the forefront of manufacturing technology for sterile pharmaceuticals, covering all critical process stages — from washing, depyrogenation, filling, to final inspection and labeling. The ultimate goal is to ensure enhanced product safety and performance throughout the manufacturing cycle.

Key Technologies at Booth #2501

Visitors can interact with technical teams from both AST and Marchesini Group USA at Booth #2501, where they'll present the latest innovations in fill-finish and inspection technologies. The focus will be on demonstrating how their integrated solutions meet the rigorous demands of the pharmaceutical industry.

1. GENiSYS® R End-To-End Robotics
The GENiSYS® R system is designed to handle flexible processing of vials, syringes, and cartridges. Its multi-format capabilities, equipped with an array of automated functions, ensure compliance with strict cGMP standards. With robotics at its core, it minimizes human interaction, thereby enhancing product protection and integrity. Advanced in-process quality control systems deploy sophisticated sensors to perform a comprehensive suite of checks, ensuring the highest standards of quality.

2. NSY 200 Automated Inspection System
The NSY 200 offers an innovative, hands-free inspection process for syringes, integrating seamlessly with the flow of production. This monobloc machine utilizes a robotic arm to pick syringes without contact, ensuring contamination-free handling. It can inspect multiple features of each syringe, including the flange, stopper, filling level, and glass wall integrity via High Voltage Leak Detection technology. Customizable reject lanes allow for streamlined sorting of non-compliant syringes.

Voices from the Leaders

Joe Hoff, President and CEO of AST, expresses excitement about this partnership and the opportunities it presents: “This partnership with Marchesini Group allows us to position AST as a leading full-service provider in the pharmaceutical manufacturing sector, significantly enhancing our service offerings across the Americas.”

Valerio Soli, the CEO of Marchesini Group, also acknowledges the positive impact of this collaboration on the U.S. market, stating, “Our partnership bolsters our capability to provide next-generation technologies and comprehensive support, particularly to the U.S. pharmaceutical market, which is crucial for advancing new therapies.”

With the expertise of AST and Marchesini Group now combined, attendees of INTERPHEX 2026 can expect to see transformative approaches to drug manufacturing technologies. Companies within the pharmaceutical landscape will gain impactful insights into how such innovations can elevate their production processes.

Conclusion

As the pharmaceutical sector embraces new challenges and innovations, the partnership between AST and Marchesini Group stands as a beacon of progress, promising enhanced solutions that prioritize product safety and efficiency. Don't miss the chance to explore these advancements at INTERPHEX 2026, where the future of drug manufacturing is on display.